CCSS Public Access GWAS Data Tables

The table below provides characteristics for genotyped CCSS participants. Please also see:

Characteristics of the CCSS Participants Genotyped#

Characteristic CCSS Participants with Genotype Data
(N=5739)
Sex N %
Male 2781 48.5%
Female 2958 51.5%
Ancestry (based on genotype)
European 5324 92.8%
Non-European 415 7.2%
Primary Cancer Diagnosis
ALL 1711 29.8%
AML 101 1.8%
Other leukemia 31 0.5%
CNS 690 12.0%
Hodgkin lymphoma 763 13.3%
Non-Hodgkin lymphoma 470 8.2%
Kidney tumor 542 9.4%
Neuroblastoma 417 8.2%
Soft tissue sarcoma 518 9.0%
Ewings sarcoma 166 2.9%
Osteosarcoma 312 5.4%
Other bone malignancy 18 0.3%
Age at Cancer Diagnosis
0-4 yrs 2244 39.1%
5-9 yrs 1270 22.1%
10-14 yrs 1202 21.0%
15-20 yrs 1023 17.8%
Year of Diagnosis
1970-1975 1300 22.7%
1976-1981 2095 36.5%
1982-1986 2344 40.8%
Radiotherapy for Primary Cancer
Yes 3556 62.0%
No 1860 32.4%
Unknown* 323 5.6%
Chemotherapy for Primary Cancer
Yes 4254 74.1%
No 1121 19.5%
Unknown* 364 6.3%

#Survivors diagnosed 1970-1986
*Participants did not provide consent for release of medical records